Related Experiment Video
Updated: Jun 10, 2026

Testing the Role of Multicopy Plasmids in the Evolution of Antibiotic Resistance
Published on: May 2, 2018
The development of ciprofloxacin resistance in Pseudomonas aeruginosa involves multiple response stages and multiple
Hsun-Cheng Su1, Kevin Ramkissoon, Janet Doolittle
1Department of Microbiology and Immunology, The University of North Carolina at Chapel Hill, Chapel Hill, NC 27599, USA.
Abstract:
Microbes have developed resistance to nearly every antibiotic, yet the steps leading to drug resistance remain unclear. Here we report a multistage process by which Pseudomonas aeruginosa acquires drug resistance following exposure to ciprofloxacin at levels ranging from 0.5× to 8× the initial MIC. In stage I, susceptible cells are killed en masse by the exposure. In stage II, a small, slow to nongrowing population survives antibiotic exposure that does not exhibit significantly increased resistance according to the MIC measure. In stage III, exhibited at 0.5× to 4× the MIC, a growing population emerges to reconstitute the population, and these cells display heritable increases in drug resistance of up to 50 times the original level. We studied the stage III cells by proteomic methods to uncover differences in the regulatory pathways that are involved in this phenotype, revealing upregulation of phosphorylation on two proteins, succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH), and also revealing upregulation of a highly conserved protein of unknown function. Transposon disruption in the encoding genes for each of these targets substantially dampened the ability of cells to develop the stage III phenotype. Considering these results in combination with computational models of resistance and genomic sequencing results, we postulate that stage III heritable resistance develops from a combination of both genomic mutations and modulation of one or more preexisting cellular pathways.
Insights
Pseudomonas aeruginosa develops significant antibiotic resistance through a three-stage process. Key proteins like SSADH and MMSADH are upregulated, enabling heritable drug resistance.
Area of Science:
- Microbiology
- Molecular Biology
- Genetics
Background:
- Antibiotic resistance is a growing global health threat.
- The precise mechanisms by which bacteria acquire drug resistance are not fully understood.
- Pseudomonas aeruginosa is an opportunistic pathogen known for its intrinsic and acquired resistance capabilities.
Purpose of the Study:
- To elucidate the multistage process of antibiotic resistance acquisition in Pseudomonas aeruginosa.
- To identify specific molecular pathways and proteins involved in the development of heritable drug resistance.
- To investigate the role of identified proteins in the emergence of the resistant phenotype.
Main Methods:
- Exposure of susceptible Pseudomonas aeruginosa to sub-inhibitory concentrations of ciprofloxacin.
- Characterization of bacterial populations across different stages of antibiotic exposure.
- Proteomic analysis to identify differentially expressed proteins and post-translational modifications in resistant cells.
- Gene disruption via transposon mutagenesis to assess the functional role of candidate proteins.
- Integration of proteomic data with computational modeling and genomic sequencing.
Main Results:
- A three-stage model of resistance development was identified: mass cell death (Stage I), survival of a non-growing population (Stage II), and emergence of a growing, highly resistant population (Stage III).
- Stage III cells exhibited up to 50-fold increase in heritable resistance to ciprofloxacin.
- Proteomic analysis revealed upregulation of phosphorylation in succinate-semialdehyde dehydrogenase (SSADH) and methylmalonate-semialdehyde dehydrogenase (MMSADH).
- A conserved protein of unknown function was also found to be upregulated.
- Disruption of genes encoding SSADH, MMSADH, or the unknown protein significantly impaired the development of Stage III resistance.
Conclusions:
- Heritable antibiotic resistance in Pseudomonas aeruginosa emerges through a multistage process involving distinct cellular responses to antibiotic pressure.
- Upregulation and phosphorylation of SSADH and MMSADH are critical for the development of Stage III resistance.
- The findings suggest that resistance development involves a combination of genomic mutations and the modulation of pre-existing cellular pathways.
- Targeting these identified pathways could offer novel strategies to combat antibiotic resistance.
More Related Videos
11:31Establishment of a High-throughput Setup for Screening Small Molecules That Modulate c-di-GMP Signaling in Pseudomonas aeruginosa
Published on: June 30, 2016
07:44Time-Lapse Epifluorescence Microscopy Imaging of Pseudomonas aeruginosa and Staphylococcus aureus Heterogeneous Phenotypes
Published on: February 14, 2025
Related Concept Videos
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Clinical Significance of Antibiotic Resistance
Inhibitors of Bacterial DNA Synthesis
Gene Regulation in Microbial Communities: Quorum Sensing
Antibiotic Selection